Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. Melatonin Inhibits ET‐1 Production to Break Crosstalk Between Prostate Cancer and Bone Cells: Implication for Osteoblastic Bone Metastasis Treatment
 
  • Details
Options

Melatonin Inhibits ET‐1 Production to Break Crosstalk Between Prostate Cancer and Bone Cells: Implication for Osteoblastic Bone Metastasis Treatment

Journal
Journal of Pineal Research
Journal Volume
76
Journal Issue
7
ISSN
0742-3098
1600-079X
Date Issued
2024-10
Author(s)
Liang‐Wei Lin
Tien‐Huang Lin
Sanskruti Swain
Jen‐Kai Fang
Jeng‐Hung Guo
Shun‐Fa Yang  
Chih‐Hsin Tang
DOI
10.1111/jpi.70000
URI
https://scholars.csmu.edu.tw/handle/123456789/5077
Abstract
<jats:title>ABSTRACT</jats:title><jats:p>Bone metastasis is the primary cause of death among patients with advanced prostate cancer (PCa). PCa tends to spread to bones and acquire the bone‐like phenotype, causing osteoblastic bone metastasis. Unfortunately, there is no effective treatment for this condition. However, melatonin, which regulates our circadian rhythm, has been found to have anti‐tumor properties. It has yet to be established whether it is effective in treating osteoblastic PCa metastasis. Our findings show that melatonin inhibits the production of endothelin‐1 (ET‐1) in osteoblastic PCa cells, suppressing osteoblast differentiation. Clinical results indicate that bone metastatic PCa patients have higher levels of ET‐1 compared to nonmetastatic PCa patients. Furthermore, melatonin‐induced miR‐let‐7f‐5p inhibits ET‐1‐promoted osteoblast differentiation in osteoblastic PCa. Melatonin also suppresses the property of osteomimicry in osteoblastic PCa cells. Importantly, in the intratibia injection PCa metastasis model, melatonin decreased osteoblastic PCa tumor growth, inhibiting ET‐1 production and osteoblast differentiation in vivo. Taken together, melatonin inhibits osteoblastic PCa‐regulated osteoblastogenesis by reducing ET‐1 production through upregulation of miR‐let‐7f‐5p, while suppressing the property of osteomimicry in osteoblastic PCa. Melatonin therapy could be a promising approach to treating bone metastasis in osteoblastic PCa.</jats:p>
SDGs

[SDGs]SDG3

Publisher
Wiley
Type
journal-article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback